On the afternoon of May 10th, the third member conference and general election conference of the Guizhou Pharmaceutical Industry Association was held at the Guizhou International Conference Center. In this election, Dou Qiling, the chairman of Guizhou Yibai Pharmaceutical Co., Ltd. (stock abbreviation: Yibai Pharmaceutical, stock code: 600594), was elected as the president of the third Guizhou Pharmaceutical Industry Association, and Dou Yaqi, the general manager, was elected as the secretary general of the third Guizhou Pharmaceutical Industry Association.

The leaders at all levels attending this event include Li Hanyu, Vice Chairman of the Guizhou Provincial Political Consultative Conference and Chairman of the Provincial Federation of Industry and Commerce, Wu Haidong, President of the China Pharmaceutical Enterprise Management Association, and Zhu Bei, a second level inspector of the Provincial Department of Industry and Information Technology.

It is understood that since the second Guizhou Pharmaceutical Industry Association Council was elected in 2017, under the leadership of higher-level units such as the Provincial Department of Industry and Information Technology and the Provincial Department of Civil Affairs, it has conscientiously fulfilled its established work goals, closely followed the industrial development layout, and continuously improved and improved its services around the purpose of being a good propagandist, waiter, and coordinator.

Over the past five years, the association has continuously improved its internal mechanisms and made great efforts to solve the remaining problems of the association. At the same time, we strengthened external communication and continued to play the role of the association as a link and bridge, which has been recognized by higher authorities and various sectors of society.

Li Hanyu pointed out that in recent years, the pharmaceutical industry in our province has made significant achievements by relying on resource advantages, highlighting regional characteristics, vigorously developing private economy, actively promoting technological progress, and adjusting product structure. The new Guizhou Pharmaceutical Industry Association needs to strengthen contact and communication with its members, provide good communication services for members, work together, innovate, and strive together, and shoulder the important responsibilities bestowed by the times and history.

At the meeting, Wu Haidong fully affirmed the work of the Guizhou Pharmaceutical Industry Association and appreciated the vision and courage of leaders at all levels in Guizhou Province to attach great importance to the pharmaceutical industry, placing it as a pillar industry and placing it in a prominent strategic position. At the same time, we commend the colleagues of the Guizhou Association for their clear understanding of their own advantages and resources, the association's full role as a bridge and link, the effective communication role with the government, and the decisive role of the market complement and complement each other.

Dou Qiling, Chairman of Yibai Pharmaceutical, proposed that the new association will establish 10 branches, including the Medicinal Materials Planting Branch, Drug Research and Development Branch, Drug Production Branch, Drug Circulation Branch, Drug Use Branch, Drug Analysis Branch, Drug Retail Branch, Medical Device Branch, Science Popularization Branch, and News Promotion Center. Among them, the news and publicity center is located on the digital channel of Guizhou Radio and Television Station. The association will implement full industry chain management, focus on serving member units wholeheartedly, become a bridge between the party, government, and enterprises, become an industry association of propagandists, coordinators, and servers, and make the association a responsible, emotional, and warm member home, making new contributions to promoting the high-quality development of the pharmaceutical industry in our province.